The unique, upstream approach taken by Mardinoglu and team to increase endogenous glutathione synthesis and reduce fatty liver (while supporting methylation balance) based on their work using personalized genome-scale metabolic models, is worth us considering in clinical practice
Pilar Francino, [email protected] Present address: Alejandra Rey-MarioDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lcteos de Asturias (IPLA-CSIC), Oviedo, Spain;Diet, Microbiota and Health Group, Instituto de Investigacin Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
ReadyRx provides pharmaceutical-grade formulations through licensed healthcare providers to ensure safety, quality, and appropriate medical supervision
GHK-Cu: The Copper Peptide That's Rewriting the Rules of Regeneration How a three-amino-acid sequence discovered in human blood became the Swiss Army knife of anti-aging medicine In the pantheon of anti-aging interventions, most compounds fall into one of two categories: the overhyped and underdelivered, or the promising but perpetually "five years away from clinical application." GHK-Cu, a copper-binding tripeptide that sounds like a military designation for classified equipment, occupies a refreshingly different space
